CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- 4 Open-market sale Chief Medical Officer sold 919 shares at $15.00 ($13,785)
- 4 Open-market sale See Remarks sold 4,392 shares at $15.10 ($66,319)
- 4 Open-market sale Chief Medical Officer sold 21,669 shares at $15.00 ($325,035)
- 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $13.00 ($97,520)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $12.00 ($60,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.67 ($53,334)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- CT ORDER Other Confidential Order
- 4 Insider Changes in Ownership
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
Page 27 of 33 · 659 filings